Research programme: serotonin 6 receptor antagonists - GlaxoSmithKlineAlternative Names: 699929; GSK215083A; SB 357134; SB 699929
Latest Information Update: 18 Apr 2011
At a glance
- Originator GlaxoSmithKline
- Class Piperazines; Sulfonamides
- Mechanism of Action Serotonin 6 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cognition disorders